Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
B Banwell, JL Bennett, R Marignier, HJ Kim… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
Myelin-oligodendrocyte glycoprotein antibody-associated disease
R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …
identified autoimmune disorder that presents in both adults and children as CNS …
Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study
Y Takai, T Misu, K Kaneko, N Chihara, K Narikawa… - Brain, 2020 - academic.oup.com
Conformation-sensitive antibodies against myelin oligodendrocyte glycoprotein (MOG) are
detectable in patients with optic neuritis, myelitis, opticomyelitis, acute or multiphasic …
detectable in patients with optic neuritis, myelitis, opticomyelitis, acute or multiphasic …
Neurological update: MOG antibody disease
R Wynford-Thomas, A Jacob, V Tomassini - Journal of neurology, 2019 - Springer
Myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOG-AD) is now recognised
as a nosological entity with specific clinical and paraclinical features to aid early diagnosis …
as a nosological entity with specific clinical and paraclinical features to aid early diagnosis …
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
S Jarius, C Lechner, EM Wendel, M Baumann… - Journal of …, 2020 - Springer
Background New-generation, cell-based assays have demonstrated a robust association of
serum autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) …
serum autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) …
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Over the past few years, new-generation cell-based assays have demonstrated a robust
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein …
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein …
Clinical characteristics and treatment of MOG-IgG–associated optic neuritis
DA Tajfirouz, MT Bhatti, JJ Chen - Current neurology and neuroscience …, 2019 - Springer
Abstract Purpose of Review Antibodies against myelin oligodendrocyte glycoprotein (MOG)
are associated with a unique acquired central nervous system demyelinating disease …
are associated with a unique acquired central nervous system demyelinating disease …
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
M Juryńczyk, A Jacob, K Fujihara, J Palace - Practical neurology, 2019 - pn.bmj.com
The field of central nervous system (CNS) inflammatory diseases has recently broadened to
include a new condition associated with pathogenic serum antibodies against myelin …
include a new condition associated with pathogenic serum antibodies against myelin …
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing
Importance Myelin oligodendrocyte glycoprotein-IgG1–associated disorder (MOGAD) is a
distinct central nervous system–demyelinating disease. Positive results on MOG-IgG1 …
distinct central nervous system–demyelinating disease. Positive results on MOG-IgG1 …